Search Results

Filter
  • 1-10 of  147 results for ""PARKINSONIAN disorders""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Exercise protects synaptic density in a rat model of Parkinson's disease.

  • Authors : Binda KH; Translational Neuropsychiatry Unit, Aarhus University, Universitetsbyen 13, Building 2b, Aarhus C 8000, Denmark; Department of Nuclear Medicine and PET, Aarhus University and Hospital, Palle Juul-Jensens Boulevard 165, J109, Aarhus N 8200, Denmark

Subjects: Brain/Brain/Brain/*metabolism ; Parkinsonian Disorders/Parkinsonian Disorders/Parkinsonian Disorders/*metabolism ; Parkinsonian Disorders/Parkinsonian Disorders/Parkinsonian Disorders/*therapy

  • Source: Experimental neurology [Exp Neurol] 2021 Aug; Vol. 342, pp. 113741. Date of Electronic Publication: 2021 May 11.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy.

  • Authors : Hulme H; Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, National Resource for Mass Spectrometry Imaging, Uppsala University, Uppsala, Sweden.

Subjects: Brain/Brain/Brain/*drug effects ; Enkephalins/Enkephalins/Enkephalins/*metabolism ; Levodopa/Levodopa/Levodopa/*pharmacology

  • Source: Neurobiology of disease [Neurobiol Dis] 2020 Apr; Vol. 137, pp. 104738. Date of Electronic Publication: 2020 Jan 10.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

GDNF signaling in subjects with minimal motor deficits and Parkinson's disease.

  • Authors : Chu Y; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, United States of America.; Kordower JH

Subjects: Prodromal Symptoms*; Brain/Brain/Brain/*metabolism ; Glial Cell Line-Derived Neurotrophic Factor/Glial Cell Line-Derived Neurotrophic Factor/Glial Cell Line-Derived Neurotrophic Factor/*metabolism

  • Source: Neurobiology of disease [Neurobiol Dis] 2021 Jun; Vol. 153, pp. 105298. Date of Electronic Publication: 2021 Mar 05.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Structural Imaging in Atypical Parkinsonism.

  • Authors : Heim B; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.; Krismer F

Subjects: Disease Progression*; Basal Ganglia Diseases/Basal Ganglia Diseases/Basal Ganglia Diseases/*diagnostic imaging ; Brain/Brain/Brain/*diagnostic imaging

  • Source: International review of neurobiology [Int Rev Neurobiol] 2018; Vol. 142, pp. 67-148. Date of Electronic Publication: 2018 Sep 24.Publisher: Academic Press Country of Publication: United States NLM ID: 0374740 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease.

  • Authors : Tagliaferro P; Departments of Neurology, Columbia University Medical Center, 650 W 168th St., New York, NY 10032, USA.; Kareva T

Subjects: Axons/Axons/Axons/*pathology ; Brain/Brain/Brain/*pathology ; Parkinsonian Disorders/Parkinsonian Disorders/Parkinsonian Disorders/*pathology

  • Source: Neurobiology of disease [Neurobiol Dis] 2015 Oct; Vol. 82, pp. 359-371. Date of Electronic Publication: 2015 Jul 17.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats.

  • Authors : Aristieta A; Department of Pharmacology, Faculty of Medicine and Dentistry, University of the Basque Country, 48940 Leioa, Spain.; Ruiz-Ortega JA

Subjects: Action Potentials/Action Potentials/Action Potentials/*drug effects ; Brain/Brain/Brain/*physiopathology ; Brain Waves/Brain Waves/Brain Waves/*drug effects

  • Source: Neurobiology of disease [Neurobiol Dis] 2016 May; Vol. 89, pp. 88-100. Date of Electronic Publication: 2016 Feb 04.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease.

  • Authors : Chu Y; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address: .; Goldman JG

Subjects: Brain/Brain/Brain/*metabolism ; Parkinson Disease/Parkinson Disease/Parkinson Disease/*metabolism ; Parkinsonian Disorders/Parkinsonian Disorders/Parkinsonian Disorders/*metabolism

  • Source: Neurobiology of disease [Neurobiol Dis] 2014 Sep; Vol. 69, pp. 1-14. Date of Electronic Publication: 2014 May 10.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Impact of DHA intake in a mouse model of synucleinopathy.

  • Authors : Coulombe K; Faculté de Pharmacie, Pavillon Ferdinand-Vandry, 1050, Avenue de la Médecine, Université Laval, Québec, QC, G1V 0A6, Canada; Centre de Recherche du CHU de Québec-Université Laval, Axe Neurosciences, 2705, Boulevard Laurier, Québec, QC, G1V 4G2, Canada

Subjects: Brain/Brain/Brain/*drug effects ; Brain/Brain/Brain/*pathology ; Docosahexaenoic Acids/Docosahexaenoic Acids/Docosahexaenoic Acids/*pharmacology

  • Source: Experimental neurology [Exp Neurol] 2018 Mar; Vol. 301 (Pt A), pp. 39-49. Date of Electronic Publication: 2017 Dec 08.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.

  • Authors : Szego ÉM; Department of Neurodegeneration and Restorative Research, Georg-August University, DFG Research Center: Molecular Physiology of the Brain (CMPB), Göttingen, 37073, Germany. ; Gerhardt E

Subjects: Brain/Brain/Brain/*metabolism ; Dopaminergic Neurons/Dopaminergic Neurons/Dopaminergic Neurons/*physiology ; Levodopa/Levodopa/Levodopa/*pharmacology

  • Source: Neurobiology of disease [Neurobiol Dis] 2012 Jan; Vol. 45 (1), pp. 591-600. Date of Electronic Publication: 2011 Oct 07.Publisher: Academic Press Country of Publication: United States NLM ID: 9500169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The role of MPTP in Parkinson's disease: connecting brain and gut?

  • Authors : Goetze O; Department of Medicine I, St. Josef-Hospital, Ruhr-University of Bochum, School of Medicine, Gudrunstrasse 56, 44791 Bochum, Germany. ; Woitalla D

Subjects: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine*; Brain/Brain/Brain/*drug effects ; Enteric Nervous System/Enteric Nervous System/Enteric Nervous System/*drug effects

  • Source: Experimental neurology [Exp Neurol] 2008 Apr; Vol. 210 (2), pp. 281-5. Date of Electronic Publication: 2008 Jan 19.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  147 results for ""PARKINSONIAN disorders""